Xbrane Biopharma Gets Swedish Regulatory Nod for Drug Import, EU Sale

MT Newswires · 3d ago
07:26 AM EST, 11/17/2026 (MT Newswires) -- The Swedish Medical Products Agency has authorized Xbrane Biopharma (XBRANE.ST) to import drugs from third-party suppliers outside the European Union or European Economic Area, according to a Tuesday release. The regulatory approval also allows the biopharmaceutical company to perform batch certification via a qualified person and subsequently distribute the medicinal products within the bloc. Xbrane said the clearance is expected to simplify its supply chain for Ximluci, its biosimilar to ranibizumab, and provide infrastructure for its daratumumab biosimilar candidate Xdarzane, as well as future products.